1,2-dimethylhydrazine increases expression EXP 6480464 1 and 2-Dimethylhydrazine results in increased expression of FBLN1 mRNA CTD PMID:27840820 1,2-dimethylhydrazine multiple interactions ISO Fbln1 (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of FBLN1 mRNA CTD PMID:22206623 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of FBLN1 mRNA CTD PMID:30723492 17beta-estradiol increases expression ISO FBLN1 (Homo sapiens) 6480464 Estradiol results in increased expression of FBLN1 mRNA CTD PMID:23019147 and PMID:25321415 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of FBLN1 mRNA CTD PMID:32145629 17beta-estradiol multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FBLN1 mRNA CTD PMID:32741896 17beta-estradiol 3-benzoate multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FBLN1 mRNA CTD PMID:32741896 2,2',5,5'-tetrachlorobiphenyl decreases expression EXP 6480464 2 more ... CTD PMID:23829299 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Fbln1 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of FBLN1 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of FBLN1 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO FBLN1 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin affects the expression of FBLN1 mRNA CTD PMID:36370075 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of FBLN1 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of FBLN1 mRNA CTD PMID:32109520 3,4-methylenedioxymethamphetamine increases expression ISO Fbln1 (Mus musculus) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of FBLN1 mRNA CTD PMID:20188158 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO FBLN1 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FBLN1 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of FBLN1 mRNA CTD PMID:28628672 3-Nitrobenzanthrone decreases expression ISO FBLN1 (Homo sapiens) 6480464 3-nitrobenzanthrone results in decreased expression of FBLN1 mRNA CTD PMID:34036453 4,4'-sulfonyldiphenol increases expression ISO Fbln1 (Mus musculus) 6480464 bisphenol S results in increased expression of FBLN1 mRNA CTD PMID:30951980 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of FBLN1 mRNA CTD PMID:36041667 4-phenylbutyric acid increases expression ISO FBLN1 (Homo sapiens) 6480464 4-phenylbutyric acid results in increased expression of FBLN1 mRNA CTD PMID:14583596 5-azacytidine increases expression ISO FBLN1 (Homo sapiens) 6480464 Azacitidine results in increased expression of FBLN1 mRNA CTD PMID:21245298 5-fluorouracil affects expression ISO FBLN1 (Homo sapiens) 6480464 Fluorouracil affects the expression of FBLN1 mRNA CTD PMID:15205334 5-fluorouracil increases expression ISO FBLN1 (Homo sapiens) 6480464 Fluorouracil results in increased expression of FBLN1 mRNA CTD PMID:17039268 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of FBLN1 mRNA CTD PMID:24780913 6alpha-methylprednisolone increases expression ISO FBLN1 (Homo sapiens) 6480464 Methylprednisolone results in increased expression of FBLN1 mRNA CTD PMID:19192274 8-Br-cAMP increases expression ISO FBLN1 (Homo sapiens) 6480464 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of FBLN1 mRNA CTD PMID:15774544 acetamide increases expression EXP 6480464 acetamide results in increased expression of FBLN1 mRNA CTD PMID:31881176 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of FBLN1 mRNA CTD PMID:28959563 acrylamide decreases expression ISO FBLN1 (Homo sapiens) 6480464 Acrylamide results in decreased expression of FBLN1 mRNA CTD PMID:32763439 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of FBLN1 mRNA CTD PMID:23630614 and PMID:25378103 aflatoxin B1 increases expression ISO FBLN1 (Homo sapiens) 6480464 Aflatoxin B1 results in increased expression of FBLN1 mRNA CTD PMID:32234424 aflatoxin B1 affects methylation ISO FBLN1 (Homo sapiens) 6480464 Aflatoxin B1 affects the methylation of FBLN1 intron CTD PMID:30157460 all-trans-retinoic acid increases expression ISO Fbln1 (Mus musculus) 6480464 Tretinoin results in increased expression of FBLN1 mRNA CTD PMID:16604517 amphotericin B increases expression ISO FBLN1 (Homo sapiens) 6480464 Amphotericin B analog results in increased expression of FBLN1 mRNA CTD PMID:28534445 arsenous acid increases expression ISO FBLN1 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of FBLN1 mRNA CTD PMID:25555879 arsenous acid multiple interactions ISO FBLN1 (Homo sapiens) 6480464 [Arsenic Trioxide co-treated with Ascorbic Acid] results in increased expression of FBLN1 mRNA CTD PMID:25555879 azathioprine increases expression ISO FBLN1 (Homo sapiens) 6480464 Azathioprine results in increased expression of FBLN1 mRNA CTD PMID:19192274 belinostat decreases expression ISO FBLN1 (Homo sapiens) 6480464 belinostat results in decreased expression of FBLN1 mRNA CTD PMID:26272509 belinostat multiple interactions ISO FBLN1 (Homo sapiens) 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FBLN1 mRNA CTD PMID:27188386 benzo[a]pyrene multiple interactions ISO Fbln1 (Mus musculus) 6480464 Benzo(a)pyrene promotes the reaction [AHR protein binds to FBLN1 promoter] CTD PMID:19654925 benzo[a]pyrene increases expression ISO FBLN1 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of FBLN1 mRNA CTD PMID:32234424 benzo[a]pyrene increases methylation ISO Fbln1 (Mus musculus) 6480464 Benzo(a)pyrene results in increased methylation of FBLN1 exon and Benzo(a)pyrene results in increased methylation of FBLN1 intron CTD PMID:27901495 benzo[a]pyrene decreases methylation ISO FBLN1 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased methylation of FBLN1 promoter CTD PMID:27901495 benzo[a]pyrene affects methylation ISO FBLN1 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of FBLN1 intron CTD PMID:30157460 benzo[a]pyrene decreases expression ISO Fbln1 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of FBLN1 mRNA CTD PMID:21569818 benzo[e]pyrene decreases methylation ISO FBLN1 (Homo sapiens) 6480464 benzo(e)pyrene results in decreased methylation of FBLN1 intron CTD PMID:30157460 bis(2-ethylhexyl) phthalate increases expression ISO FBLN1 (Homo sapiens) 6480464 Diethylhexyl Phthalate results in increased expression of FBLN1 mRNA CTD PMID:31163220 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of FBLN1 mRNA CTD PMID:25181051 more ... bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of FBLN1 mRNA CTD PMID:36041667 bisphenol A decreases methylation ISO FBLN1 (Homo sapiens) 6480464 bisphenol A results in decreased methylation of FBLN1 gene CTD PMID:31601247 bisphenol A decreases expression ISO Fbln1 (Mus musculus) 6480464 bisphenol A results in decreased expression of FBLN1 mRNA CTD PMID:37894381 bisphenol A affects expression ISO FBLN1 (Homo sapiens) 6480464 bisphenol A affects the expression of FBLN1 mRNA CTD PMID:30903817 bisphenol A increases expression ISO FBLN1 (Homo sapiens) 6480464 bisphenol A results in increased expression of FBLN1 mRNA CTD PMID:29275510 bisphenol A increases expression ISO Fbln1 (Mus musculus) 6480464 bisphenol A results in increased expression of FBLN1 mRNA CTD PMID:30951980 and PMID:37105096 bisphenol A multiple interactions ISO FBLN1 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of FBLN1 gene and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FBLN1 mRNA CTD PMID:28628672 and PMID:31601247 bisphenol F multiple interactions ISO FBLN1 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of FBLN1 mRNA CTD PMID:28628672 bisphenol F multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of FBLN1 mRNA CTD PMID:36041667 bisphenol F increases expression ISO Fbln1 (Mus musculus) 6480464 bisphenol F results in increased expression of FBLN1 mRNA CTD PMID:30951980 butan-1-ol multiple interactions ISO FBLN1 (Homo sapiens) 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of FBLN1 mRNA CTD PMID:29432896 cadmium atom multiple interactions ISO Fbln1 (Mus musculus) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of FBLN1 mRNA CTD PMID:37325564 cadmium dichloride multiple interactions ISO Fbln1 (Mus musculus) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of FBLN1 mRNA CTD PMID:37325564 calcitriol decreases expression ISO FBLN1 (Homo sapiens) 6480464 Calcitriol results in decreased expression of FBLN1 mRNA CTD PMID:26485663 cantharidin decreases expression ISO Fbln1 (Mus musculus) 6480464 Cantharidin results in decreased expression of FBLN1 mRNA CTD PMID:36907384 carbon nanotube affects expression ISO Fbln1 (Mus musculus) 6480464 Nanotubes and Carbon affects the expression of FBLN1 mRNA CTD PMID:25554681 carbon nanotube decreases expression ISO Fbln1 (Mus musculus) 6480464 Nanotubes and Carbon analog results in decreased expression of FBLN1 mRNA CTD PMID:25554681 cefaloridine increases expression EXP 6480464 Cephaloridine results in increased expression of FBLN1 mRNA CTD PMID:18500788 chlormequat chloride increases expression EXP 6480464 Chlormequat results in increased expression of FBLN1 protein CTD PMID:34958886 chromium(6+) affects expression ISO Fbln1 (Mus musculus) 6480464 chromium hexavalent ion affects the expression of FBLN1 mRNA CTD PMID:28472532 cobalt dichloride decreases secretion ISO FBLN1 (Homo sapiens) 6480464 cobaltous chloride results in decreased secretion of FBLN1 protein CTD PMID:22079246 copper atom increases expression EXP 6480464 Copper deficiency results in increased expression of FBLN1 mRNA CTD PMID:26033743 copper atom decreases expression EXP 6480464 Copper results in decreased expression of FBLN1 mRNA CTD PMID:30556269 copper atom multiple interactions EXP 6480464 [Copper deficiency co-treated with tetrathiomolybdate] results in decreased expression of FBLN1 mRNA and [Copper deficiency co-treated with tetrathiomolybdate] results in decreased expression of FBLN1 protein CTD PMID:22276220 copper(0) increases expression EXP 6480464 Copper deficiency results in increased expression of FBLN1 mRNA CTD PMID:26033743 copper(0) decreases expression EXP 6480464 Copper results in decreased expression of FBLN1 mRNA CTD PMID:30556269 copper(0) multiple interactions EXP 6480464 [Copper deficiency co-treated with tetrathiomolybdate] results in decreased expression of FBLN1 mRNA and [Copper deficiency co-treated with tetrathiomolybdate] results in decreased expression of FBLN1 protein CTD PMID:22276220 copper(II) sulfate decreases expression ISO FBLN1 (Homo sapiens) 6480464 Copper Sulfate results in decreased expression of FBLN1 mRNA CTD PMID:19549813 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of FBLN1 mRNA CTD PMID:26577399 and PMID:27523638 cytarabine decreases expression ISO FBLN1 (Homo sapiens) 6480464 Cytarabine results in decreased expression of FBLN1 mRNA CTD PMID:21198554 decabromodiphenyl ether decreases expression EXP 6480464 decabromobiphenyl ether results in decreased expression of FBLN1 mRNA CTD PMID:23640034 dexamethasone increases expression ISO Fbln1 (Mus musculus) 6480464 Dexamethasone results in increased expression of FBLN1 mRNA CTD PMID:22733784 dexamethasone multiple interactions ISO FBLN1 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FBLN1 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of FBLN1 mRNA CTD PMID:28628672 diarsenic trioxide increases expression ISO FBLN1 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of FBLN1 mRNA CTD PMID:25555879 diarsenic trioxide multiple interactions ISO FBLN1 (Homo sapiens) 6480464 [Arsenic Trioxide co-treated with Ascorbic Acid] results in increased expression of FBLN1 mRNA CTD PMID:25555879 dibenz[a,h]anthracene increases expression ISO Fbln1 (Mus musculus) 6480464 1 more ... CTD PMID:26377693 dimethylarsinic acid decreases expression EXP 6480464 Cacodylic Acid results in decreased expression of FBLN1 mRNA CTD PMID:37567419 dioxygen multiple interactions ISO Fbln1 (Mus musculus) 6480464 [sulforaphane affects the susceptibility to Oxygen] which affects the expression of FBLN1 mRNA CTD PMID:30529165 dioxygen multiple interactions EXP 6480464 [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of FBLN1 mRNA CTD PMID:33729688 diquat decreases expression ISO Fbln1 (Mus musculus) 6480464 Diquat results in decreased expression of FBLN1 mRNA CTD PMID:36851058 diuron increases expression EXP 6480464 Diuron results in increased expression of FBLN1 mRNA CTD PMID:21551480 dorsomorphin multiple interactions ISO FBLN1 (Homo sapiens) 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin increases expression ISO Fbln1 (Mus musculus) 6480464 Doxorubicin results in increased expression of FBLN1 mRNA CTD PMID:15033991 doxorubicin decreases expression ISO FBLN1 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of FBLN1 mRNA CTD PMID:29803840 doxorubicin affects expression ISO FBLN1 (Homo sapiens) 6480464 Doxorubicin affects the expression of FBLN1 mRNA CTD PMID:15205334 elemental selenium increases expression ISO FBLN1 (Homo sapiens) 6480464 Selenium results in increased expression of FBLN1 mRNA CTD PMID:19244175 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of FBLN1 mRNA CTD PMID:29391264 ethanol increases expression ISO Fbln1 (Mus musculus) 6480464 Ethanol results in increased expression of FBLN1 mRNA CTD PMID:30319688 folic acid multiple interactions ISO Fbln1 (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of FBLN1 mRNA CTD PMID:22206623 fulvestrant increases methylation ISO FBLN1 (Homo sapiens) 6480464 Fulvestrant results in increased methylation of FBLN1 gene CTD PMID:31601247 fulvestrant multiple interactions ISO FBLN1 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of FBLN1 gene CTD PMID:31601247 furan increases expression EXP 6480464 furan results in increased expression of FBLN1 mRNA CTD PMID:27387713 genistein increases expression ISO FBLN1 (Homo sapiens) 6480464 Genistein results in increased expression of FBLN1 mRNA CTD PMID:23019147 glycidyl methacrylate decreases expression ISO FBLN1 (Homo sapiens) 6480464 glycidyl methacrylate results in decreased expression of FBLN1 protein CTD PMID:36641056 hydrogen cyanide decreases expression ISO Fbln1 (Mus musculus) 6480464 Hydrogen Cyanide results in decreased expression of FBLN1 mRNA CTD PMID:33914522 hydrogen peroxide affects expression ISO FBLN1 (Homo sapiens) 6480464 Hydrogen Peroxide affects the expression of FBLN1 mRNA CTD PMID:20044591 indometacin multiple interactions ISO FBLN1 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of FBLN1 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of FBLN1 mRNA CTD PMID:28628672 inulin multiple interactions ISO Fbln1 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of FBLN1 mRNA CTD PMID:36331819 isotretinoin increases expression ISO FBLN1 (Homo sapiens) 6480464 Isotretinoin results in increased expression of FBLN1 mRNA CTD PMID:20436886 ivermectin decreases expression ISO FBLN1 (Homo sapiens) 6480464 Ivermectin results in decreased expression of FBLN1 protein CTD PMID:32959892 L-ascorbic acid increases expression ISO FBLN1 (Homo sapiens) 6480464 Ascorbic Acid results in increased expression of FBLN1 mRNA CTD PMID:25555879 L-ascorbic acid multiple interactions ISO FBLN1 (Homo sapiens) 6480464 [arsenic trioxide co-treated with Ascorbic Acid] results in increased expression of FBLN1 mRNA CTD PMID:25555879 medroxyprogesterone acetate increases expression ISO FBLN1 (Homo sapiens) 6480464 Medroxyprogesterone Acetate results in increased expression of FBLN1 mRNA and Medroxyprogesterone Acetate results in increased expression of FBLN1 protein CTD PMID:15774544 medroxyprogesterone acetate multiple interactions ISO FBLN1 (Homo sapiens) 6480464 Mifepristone inhibits the reaction [Medroxyprogesterone Acetate results in increased expression of FBLN1 mRNA] CTD PMID:15774544 menadione affects expression ISO FBLN1 (Homo sapiens) 6480464 Vitamin K 3 affects the expression of FBLN1 mRNA CTD PMID:20044591 methapyrilene decreases methylation ISO FBLN1 (Homo sapiens) 6480464 Methapyrilene results in decreased methylation of FBLN1 intron CTD PMID:30157460 methotrexate increases expression ISO FBLN1 (Homo sapiens) 6480464 Methotrexate results in increased expression of FBLN1 mRNA CTD PMID:19192274 methylmercury chloride increases expression ISO FBLN1 (Homo sapiens) 6480464 methylmercuric chloride results in increased expression of FBLN1 mRNA CTD PMID:23179753 microcystin-LR increases expression EXP 6480464 cyanoginosin LR results in increased expression of FBLN1 mRNA CTD PMID:34740672 mifepristone multiple interactions ISO FBLN1 (Homo sapiens) 6480464 Mifepristone inhibits the reaction [Medroxyprogesterone Acetate results in increased expression of FBLN1 mRNA] CTD PMID:15774544 mifepristone decreases expression ISO FBLN1 (Homo sapiens) 6480464 Mifepristone results in decreased expression of FBLN1 mRNA CTD PMID:17584828 monosodium L-glutamate decreases expression ISO Fbln1 (Mus musculus) 6480464 Sodium Glutamate results in decreased expression of FBLN1 mRNA CTD PMID:22078008 N,N-diethyl-m-toluamide multiple interactions EXP 6480464 [Permethrin co-treated with DEET] affects the methylation of FBLN1 gene CTD PMID:33148267 N-methyl-4-phenylpyridinium increases expression ISO Fbln1 (Mus musculus) 6480464 1-Methyl-4-phenylpyridinium results in increased expression of FBLN1 protein CTD PMID:26558463 N-nitrosodiethylamine increases expression ISO Fbln1 (Mus musculus) 6480464 Diethylnitrosamine results in increased expression of FBLN1 mRNA CTD PMID:17854601 N-nitrosodiethylamine multiple interactions ISO Fbln1 (Mus musculus) 6480464 RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of FBLN1 mRNA] CTD PMID:17854601 ozone multiple interactions ISO Fbln1 (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of FBLN1 mRNA and [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of FBLN1 mRNA CTD PMID:34911549 paracetamol affects expression ISO Fbln1 (Mus musculus) 6480464 Acetaminophen affects the expression of FBLN1 mRNA CTD PMID:17562736 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of FBLN1 mRNA CTD PMID:33387578 paracetamol increases expression ISO FBLN1 (Homo sapiens) 6480464 Acetaminophen results in increased expression of FBLN1 mRNA CTD PMID:22230336 PCB138 decreases expression EXP 6480464 2 more ... CTD PMID:23829299 pentane-2,3-dione decreases expression EXP 6480464 2 and 3-pentanedione results in decreased expression of FBLN1 mRNA CTD PMID:25710175 perfluorohexanesulfonic acid decreases expression ISO Fbln1 (Mus musculus) 6480464 perfluorohexanesulfonic acid results in decreased expression of FBLN1 mRNA CTD PMID:37995155 perfluorooctane-1-sulfonic acid multiple interactions ISO Fbln1 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of FBLN1 mRNA CTD PMID:36331819 perfluorooctanoic acid increases expression ISO Fbln1 (Mus musculus) 6480464 perfluorooctanoic acid results in increased expression of FBLN1 protein CTD PMID:36214631 permethrin multiple interactions EXP 6480464 [Permethrin co-treated with DEET] affects the methylation of FBLN1 gene CTD PMID:33148267 phenobarbital multiple interactions ISO Fbln1 (Mus musculus) 6480464 NR1I3 protein affects the reaction [Phenobarbital results in increased expression of FBLN1 mRNA] CTD PMID:19482888 phenobarbital increases expression ISO Fbln1 (Mus musculus) 6480464 Phenobarbital results in increased expression of FBLN1 mRNA CTD PMID:19482888 phenylmercury acetate decreases expression ISO FBLN1 (Homo sapiens) 6480464 Phenylmercuric Acetate results in decreased expression of FBLN1 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO FBLN1 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FBLN1 mRNA CTD PMID:27188386 pioglitazone increases expression ISO FBLN1 (Homo sapiens) 6480464 Pioglitazone results in increased expression of FBLN1 mRNA CTD PMID:30031879 pirinixic acid decreases expression ISO Fbln1 (Mus musculus) 6480464 pirinixic acid results in decreased expression of FBLN1 mRNA CTD PMID:17426115 potassium chromate decreases expression ISO FBLN1 (Homo sapiens) 6480464 potassium chromate(VI) results in decreased expression of FBLN1 mRNA CTD PMID:22714537 potassium cyanide increases expression ISO Fbln1 (Mus musculus) 6480464 Potassium Cyanide results in increased expression of FBLN1 mRNA CTD PMID:33914522 potassium dichromate increases expression ISO Fbln1 (Mus musculus) 6480464 Potassium Dichromate results in increased expression of FBLN1 mRNA CTD PMID:23608068 potassium dichromate increases expression ISO FBLN1 (Homo sapiens) 6480464 Potassium Dichromate results in increased expression of FBLN1 protein CTD PMID:23718831 prednisolone increases expression ISO FBLN1 (Homo sapiens) 6480464 Prednisolone results in increased expression of FBLN1 mRNA CTD PMID:19192274 progesterone increases expression ISO FBLN1 (Homo sapiens) 6480464 Progesterone results in increased expression of FBLN1 mRNA CTD PMID:15774544 sarin decreases expression ISO FBLN1 (Homo sapiens) 6480464 Sarin results in decreased expression of FBLN1 mRNA CTD PMID:19522546 SB 431542 multiple interactions ISO FBLN1 (Homo sapiens) 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 selenium atom increases expression ISO FBLN1 (Homo sapiens) 6480464 Selenium results in increased expression of FBLN1 mRNA CTD PMID:19244175 silicon dioxide decreases expression ISO FBLN1 (Homo sapiens) 6480464 Silicon Dioxide analog results in decreased expression of FBLN1 mRNA CTD PMID:25895662 silicon dioxide increases expression ISO FBLN1 (Homo sapiens) 6480464 Silicon Dioxide analog results in increased expression of FBLN1 mRNA CTD PMID:23806026 sirolimus increases expression EXP 6480464 Sirolimus results in increased expression of FBLN1 mRNA CTD PMID:21865292 sodium arsenite decreases expression ISO FBLN1 (Homo sapiens) 6480464 sodium arsenite results in decreased expression of FBLN1 mRNA CTD PMID:22714537 sodium arsenite increases expression ISO Fbln1 (Mus musculus) 6480464 sodium arsenite results in increased expression of FBLN1 mRNA CTD PMID:37682722 sodium arsenite decreases methylation ISO FBLN1 (Homo sapiens) 6480464 sodium arsenite results in decreased methylation of FBLN1 intron CTD PMID:32844245 sodium arsenite increases expression ISO FBLN1 (Homo sapiens) 6480464 sodium arsenite results in increased expression of FBLN1 mRNA CTD PMID:29301061 and PMID:32844245 sodium arsenite decreases expression ISO Fbln1 (Mus musculus) 6480464 sodium arsenite results in decreased expression of FBLN1 mRNA CTD PMID:18812580 sodium aurothiomalate increases expression ISO FBLN1 (Homo sapiens) 6480464 Gold Sodium Thiomalate results in increased expression of FBLN1 mRNA CTD PMID:19192274 Soman increases expression EXP 6480464 Soman results in increased expression of FBLN1 mRNA CTD PMID:19281266 sulforaphane multiple interactions ISO Fbln1 (Mus musculus) 6480464 [sulforaphane affects the susceptibility to Oxygen] which affects the expression of FBLN1 mRNA CTD PMID:30529165 sunitinib decreases expression ISO FBLN1 (Homo sapiens) 6480464 Sunitinib results in decreased expression of FBLN1 mRNA CTD PMID:31533062 tacrolimus hydrate increases expression EXP 6480464 Tacrolimus results in increased expression of FBLN1 mRNA CTD PMID:21865292 temozolomide increases expression ISO FBLN1 (Homo sapiens) 6480464 Temozolomide results in increased expression of FBLN1 mRNA CTD PMID:31758290 tert-butyl hydroperoxide decreases expression ISO FBLN1 (Homo sapiens) 6480464 tert-Butylhydroperoxide results in decreased expression of FBLN1 mRNA CTD PMID:15336504 testosterone multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FBLN1 mRNA CTD PMID:32741896 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of FBLN1 mRNA CTD PMID:31150632 tetrathiomolybdate(2-) multiple interactions EXP 6480464 [Copper deficiency co-treated with tetrathiomolybdate] results in decreased expression of FBLN1 mRNA and [Copper deficiency co-treated with tetrathiomolybdate] results in decreased expression of FBLN1 protein CTD PMID:22276220 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of FBLN1 mRNA CTD PMID:23411599 titanium dioxide decreases expression ISO Fbln1 (Mus musculus) 6480464 titanium dioxide results in decreased expression of FBLN1 mRNA CTD PMID:23557971 and PMID:27760801 trichloroethene decreases expression ISO Fbln1 (Mus musculus) 6480464 Trichloroethylene results in decreased expression of FBLN1 mRNA CTD PMID:25549359 trichostatin A multiple interactions ISO FBLN1 (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FBLN1 mRNA CTD PMID:27188386 trichostatin A increases expression ISO FBLN1 (Homo sapiens) 6480464 trichostatin A results in increased expression of FBLN1 mRNA CTD PMID:24935251 more ... triclosan increases expression ISO FBLN1 (Homo sapiens) 6480464 Triclosan results in increased expression of FBLN1 mRNA CTD PMID:30510588 trimellitic anhydride decreases expression ISO Fbln1 (Mus musculus) 6480464 trimellitic anhydride results in decreased expression of FBLN1 mRNA CTD PMID:19042947 tunicamycin decreases expression ISO FBLN1 (Homo sapiens) 6480464 Tunicamycin results in decreased expression of FBLN1 mRNA CTD PMID:22378314 valproic acid decreases expression ISO FBLN1 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of FBLN1 mRNA CTD PMID:23179753 more ... valproic acid affects expression ISO FBLN1 (Homo sapiens) 6480464 Valproic Acid affects the expression of FBLN1 mRNA CTD PMID:25979313 valproic acid increases expression ISO Fbln1 (Mus musculus) 6480464 Valproic Acid results in increased expression of FBLN1 mRNA CTD PMID:24896083 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of FBLN1 mRNA CTD PMID:23034163 vitamin E increases expression ISO FBLN1 (Homo sapiens) 6480464 Vitamin E results in increased expression of FBLN1 mRNA CTD PMID:19244175 vorinostat multiple interactions ISO FBLN1 (Homo sapiens) 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FBLN1 mRNA CTD PMID:27188386 zoledronic acid increases expression ISO FBLN1 (Homo sapiens) 6480464 zoledronic acid results in increased expression of FBLN1 mRNA and zoledronic acid results in increased expression of FBLN1 protein CTD PMID:24714768 and PMID:28871336